Free Trial

Werewolf Therapeutics (HOWL) Insider Trading & Ownership

Werewolf Therapeutics logo
$1.08 -0.06 (-5.26%)
Closing price 04:00 PM Eastern
Extended Trading
$1.07 -0.01 (-0.83%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Werewolf Therapeutics (NASDAQ:HOWL) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
21.10%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$435,273.40
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$4,607.40
Get HOWL Insider Trade Alerts

Want to know when executives and insiders are buying or selling Werewolf Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

HOWL Insider Buying and Selling by Quarter

Werewolf Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/14/2025Ra Capital Management, L.P.DirectorBuy162,539$0.98$159,288.22  
5/12/2025Ra Capital Management, L.P.DirectorBuy320,913$0.86$275,985.18  
3/27/2025Bioventures 2014 L.P. MpmMajor ShareholderSell1,963$1.05$2,061.15  
3/27/2025Luke EvninDirectorSell2,425$1.05$2,546.25  
(Data available from 1/1/2013 forward)

HOWL Insider Trading Activity - Frequently Asked Questions

The list of insiders at Werewolf Therapeutics includes Bioventures 2014 L.P. Mpm, Luke Evnin, and Ra Capital Management, L.P.. Learn more on insiders at HOWL.

21.10% of Werewolf Therapeutics stock is owned by insiders. Learn more on HOWL's insider holdings.

The following insider purchased HOWL shares in the last 24 months: Ra Capital Management, L.P. ($435,273.40).

Insiders have purchased a total of 483,452 HOWL shares in the last 24 months for a total of $435,273.40 bought.

The following insiders have sold HOWL shares in the last 24 months: Bioventures 2014 L.P. Mpm ($2,061.15), and Luke Evnin ($2,546.25).

Insiders have sold a total of 4,388 Werewolf Therapeutics shares in the last 24 months for a total of $4,607.40 sold.

Werewolf Therapeutics Key Executives

  • Dr. Daniel J. Hicklin Ph.D. (Age 60)
    Founder, CEO, President, Secretary & Director
    Compensation: $928.26k
  • Mr. Timothy W. Trost CPA (Age 66)
    CFO, Treasurer & Assistant Secretary
    Compensation: $662.99k
  • Dr. Randi Isaacs M.D. (Age 68)
    Chief Medical Officer
    Compensation: $702.43k
  • Dr. Chulani Karunatilake Ph.D. (Age 64)
    Chief Technology Officer
    Compensation: $343.43k
  • Ms. Ellen A. Lubman M.B.A. (Age 48)
    Chief Business Officer


This page (NASDAQ:HOWL) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners